Skip to Content
← Back to Metabolic Library

Fish Oil LC PUFAs Do Not Affect Blood Coagulation

This research analyzed eight clinical studies involving more than 600 patients to investigate whether fish oil supplements increase bleeding risk—a concern that has persisted in medical circles for years. The study looked at patients with serious health conditions, including those in intensive care units and people taking blood-thinning medications, who consumed omega-3 fatty acids (EPA and DHA) from fish oil.

The researchers measured key blood clotting factors and monitored patients for any bleeding-related side effects. They tested various doses, including very high amounts up to 10 grams per day for short periods, and more moderate doses above 1.5 grams daily for up to one year. The patients studied included vulnerable populations such as elderly individuals and those with conditions like gastrointestinal cancer.

The results were reassuring: no increased bleeding risk was observed in any of the patient groups, and blood clotting measurements remained normal throughout the studies. This held true even for patients already taking blood-thinning medications, who are typically at higher risk for bleeding complications.

For those interested in metabolic health and longevity, this finding is significant because omega-3 fatty acids offer numerous benefits including reduced inflammation, improved heart health, and better brain function. However, some people have avoided fish oil supplements due to concerns about bleeding risk, particularly if they're on medications or have health conditions. This research suggests these concerns may be unfounded, potentially opening the door for more people to safely benefit from omega-3 supplementation under proper medical guidance.

Source Document Download PDF →

Disclaimer: This summary is AI-generated for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making health decisions.